ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
annotationdescriptiontagsN (males)age (years)primary reference(s)secondary reference(s)
2
('abagen', 'genepc1', 'fsaverage', '10k')PC1 of genes in the Allen Human Brain Atlasgenetics6 (5)24-55Hawrylycz et al., 2012, Nature (doi:10.1038/nature11405)
Markello et al., 2021, eLife (doi.org/10.7554/eLife.72129)
3
('aghourian2017', 'feobv', 'MNI152', '1mm')PET tracer binding (SUVR) to VAChT (acetylcholine transporter)receptors; PET18 (5)66.8 +/- 6.8Aghourian et al., 2017, Mol Psychiatry (doi:10.1038/mp.2017.183)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)
4
('alarkurtti2015', 'raclopride', 'MNI152', '3mm')PET tracer binding (BPnd) to D2 (dopamine receptor)receptors; PET7 (7)24 +/- 2
Alakurtti et al., 2015, J Cereb Blood Flow Metab (doi.org/10.1038/jcbfm.2015.53)
5
('bedard2019', 'feobv', 'MNI152', '1mm')PET tracer binding (SUVR) to VAChT (acetylcholine transporter)receptors; PET5 (4)68.3 +/- 3.1Bedard et al., 2019, Sleep Med (doi.org/10.1016/j.sleep.2018.12.020)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)
6
('beliveau2017', 'az10419369', 'MNI152', '1mm')PET tracer binding (Bmax) to 5-HT1b (serotonin receptor)receptors; PET36 (24)27.8 +/- 6.9Beliveau et al., 2017, J Neurosci (doi.org/10.1523/JNEUROSCI.2830-16.2016)
7
('beliveau2017', 'az10419369', 'fsaverage', '164k')
PET tracer binding (Bmax) to 5-HT1b (serotonin receptor)receptors; PET36 (24)27.8 +/- 6.9Beliveau et al., 2017, J Neurosci (doi.org/10.1523/JNEUROSCI.2830-16.2016)
8
('beliveau2017', 'cimbi36', 'MNI152', '1mm')PET tracer binding (Bmax) to 5-HT2a (serotonin receptor)receptors; PET29 (15)22.6 +/- 2.7Beliveau et al., 2017, J Neurosci (doi.org/10.1523/JNEUROSCI.2830-16.2016)
9
('beliveau2017', 'cimbi36', 'fsaverage', '164k')PET tracer binding (Bmax) to 5-HT2a (serotonin receptor)receptors; PET29 (15)22.6 +/- 2.7Beliveau et al., 2017, J Neurosci (doi.org/10.1523/JNEUROSCI.2830-16.2016)
10
('beliveau2017', 'cumi101', 'MNI152', '1mm')PET tracer binding (Bmax) to 5-HT1a (serotonin receptor)receptors; PET8 (3)28.4 +/- 8.8Beliveau et al., 2017, J Neurosci (doi.org/10.1523/JNEUROSCI.2830-16.2016)
11
('beliveau2017', 'cumi101', 'fsaverage', '164k')PET tracer binding (Bmax) to 5-HT1a (serotonin receptor)receptors; PET8 (3)28.4 +/- 8.8Beliveau et al., 2017, J Neurosci (doi.org/10.1523/JNEUROSCI.2830-16.2016)
12
('beliveau2017', 'dasb', 'MNI152', '1mm')PET tracer binding (Bmax) to 5-HTT (serotonin transporter)receptors; PET100 (29)25.1 +/- 5.8Beliveau et al., 2017, J Neurosci (doi.org/10.1523/JNEUROSCI.2830-16.2016)
13
('beliveau2017', 'dasb', 'fsaverage', '164k')PET tracer binding (Bmax) to 5-HTT (serotonin transporter)receptors; PET100 (29)25.1 +/- 5.8Beliveau et al., 2017, J Neurosci (doi.org/10.1523/JNEUROSCI.2830-16.2016)
14
('beliveau2017', 'sb207145', 'MNI152', '1mm')PET tracer binding (Bmax) to 5-HT4 (serotonin receptor)receptors; PET59 (41)25.9 +/- 5.3Beliveau et al., 2017, J Neurosci (doi.org/10.1523/JNEUROSCI.2830-16.2016)
15
('beliveau2017', 'sb207145', 'fsaverage', '164k')PET tracer binding (Bmax) to 5-HT4 (serotonin receptor)receptors; PET59 (41)25.9 +/- 5.3Beliveau et al., 2017, J Neurosci (doi.org/10.1523/JNEUROSCI.2830-16.2016)
16
('ding2010', 'mrb', 'MNI152', '1mm')PET tracer binding (BPnd) to NET (norepinephrine transporter)receptors; PET77 (50)33.4 +/- 9.17Ding et al., 2010, Synapse (doi.org/10.1002/syn.20696)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)		Li et al 2014 Neuroimage (doi.org/10.1016/j.neuroimage.2013.10.004)
Sanchez-Rangel et al 2020 J Int Obesity (doi.org/10.1038/s41366-019-0471-4)
Belfort-DeAguiar et al 2018 J Clin Endocrinol Metab (doi.org/10.1210/jc.2017-02717)
17
('dubois2015', 'abp688', 'MNI152', '1mm')PET tracer binding (BPnd) to mGluR5 (glutamate receptor)receptors; PET28 (15)33.1 +/- 11.2Dubois et al., 2016, Eur J Nucl Med Mol Imaging (doi.org/10.1007/s00259-015-3167-6)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)
18
('dukart2018', 'flumazenil', 'MNI152', '3mm')PET tracer binding (BPnd) to GABAa (gaba receptor)receptors; PET6 (6)43 +/- 4Dukart et al., 2018, Sci Rep (doi.org/10.1038/s41598-018-22444-0)
19
('dukart2018', 'fpcit', 'MNI152', '3mm')SPECT tracer binding (SUVR) to DAT (dopamine transporter)receptors; PET174 (109)61 +/- 11Dukart et al., 2018, Sci Rep (doi.org/10.1038/s41598-018-22444-0)
20
('fazio2016', 'madam', 'MNI152', '3mm')PET tracer binding (BPnd) to 5-HTT (serotonin transporter)receptors; PET10 (8)51-67Fazio et al., 2016, Neuroimage (doi.org/10.1016/j.neuroimage.2016.03.019)
21
('finnema2016', 'ucbj', 'MNI152', '1mm')PET tracer binding (BPnd) to SV2A (synaptic vesicle glycoprotein 2A, a synapse marker)PET76 (45)48.9 +/- 18.4Finnema et al., 2018, J Cereb Blood Flow Metab (doi.org/10.1177/0271678X17724947)
Naganawa et al., 2021 J Nucl Med (doi.org/10.2967/jnumed.120.249144)
Hansen et al., 2022, Nat Commun (doi.org/10.1038/s41467-022-32420-y)		Chen et al 2021 J Cereb Blood Flow Metab (doi.org/10.1177/0271678X211004312)
O’Dell et al 2021 Alzheimers Res Ther (doi.org/10.1186/s13195-020-00742-y)
Smart et al 2021 J Cereb Blood Flow Metab (doi.org/10.1177/0271678X20946198)
Weiss et al 2021 Clin Infect Dis (doi.org/10.1093/cid/ciab484)
Radhakrishnan et al 2021 Mol Psychiatr (doi.org/10.1038/s41380-021-01184-0)
D’Souza et al 2021 Mol Psychiatr (doi.org/10.1038/s41380-020-00891-4)
Finnema et al 2020 Epilepsia (doi.org/10.1111/epi.16653)
Bini et al 2020 EJNMMI Res (doi.org/10.1186/s13550-020-00670-w)
Mecca et al 2020 Alzheimers Dement (doi.org/10.1002/alz.12097)
Finnema et al 2019 Epilepsia (doi.org/10.1111/epi.14701)
Holmes et al 2019 Nat Commun (doi.org/10.1038/s41467-019-09562-7)
Chen et al 2018 JAMA Neurol (doi.org/10.1001/jamaneurol.2018.1836)
22
('gallezot2010', 'p943', 'MNI152', '1mm')PET tracer binding (BPnd) to 5-HT1b (serotonin receptor)receptors; PET65 (49)28.7 +/- 7Gallezot et al., 2010, J Cereb Blood Flow Metab (doi.org/10.1038/jcbfm.2009.195)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)		Murrough et al. 2010 Psychopharm (doi.org/10.1007/s00213-010-1881-0)
Murrough et al. 2011 Arch Gen Psychiatry (doi.org/10.1001/archgenpsychiatry.2011.91)
Matuskey et al. 2014 Biol Psychiatry (doi.org/10.1016/j.biopsych.2013.11.022)
Pittenger et al 2016 J Affect Disord (doi.org/10.1016/j.jad.2016.02.021)
Saricicek et al 2015 Eur J Nucl Med Mol Imaging (doi.org/10.1007/s00259-014-2958-5)
Baldassarri et al 2020 Synapse (doi.org/10.1002/syn.22159)
23
('gallezot2017', 'gsk189254', 'MNI152', '1mm')PET tracer binding (Vt) to H3 (histamine receptor)receptors; PET8 (7)31.69 +- 8.95Gallezot et al., 2017, J Cereb Blood Flow Metab (doi.org/10.1177/0271678X16650697)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)		Ashworth et al., 2010, J Nucl Med (doi.org/10.2967/jnumed.109.071753)
24
('galovic2021', 'ge179', 'MNI152', '1mm')PET tracer binding (Vt) to NMDA (glutamate receptor)receptors; PET29 (21)40.9 +/- 12.7Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)Galovic et al., 2021, bioRxiv (doi.org/10.1101/2021.12.04.21267226)
Galovic et al., 2021, NeuroImage (doi.org/10.1016/j.neuroimage.2021.118194)
McGinnity et al., 2014, J Nucl Med (doi.org/10.2967/jnumed.113.130641)
25
('hcps1200', 'megalpha', 'fsLR', '4k')
MEG alpha (8-12 Hz) power distribution from the Human Connectome Project S1200 release
MEG; functional33 (17)22-35Shafiei et al., 2022, Plos Biology (doi.org/10.1371/journal.pbio.3001735)
Van Essen et al., 2013, Neuroimage (doi.org/10.1016/j.neuroimage.2013.05.041)
26
('hcps1200', 'megbeta', 'fsLR', '4k')
MEG beta (15-29 Hz) power distribution from the Human Connectome Project S1200 release
MEG; functional33 (17)22-35Shafiei et al., 2022, Plos Biology (doi.org/10.1371/journal.pbio.3001735)
Van Essen et al., 2013, Neuroimage (doi.org/10.1016/j.neuroimage.2013.05.041)
27
('hcps1200', 'megdelta', 'fsLR', '4k')
MEG delta (2-4 Hz) power distribution from the Human Connectome Project S1200 release
MEG; functional33 (17)22-35Shafiei et al., 2022, Plos Biology (doi.org/10.1371/journal.pbio.3001735)
Van Essen et al., 2013, Neuroimage (doi.org/10.1016/j.neuroimage.2013.05.041)
28
('hcps1200', 'meggamma1', 'fsLR', '4k')
MEG low gamma (30-59 Hz) power distribution from the Human Connectome Project S1200 release
MEG; functional33 (17)22-35Shafiei et al., 2022, Plos Biology (doi.org/10.1371/journal.pbio.3001735)
Van Essen et al., 2013, Neuroimage (doi.org/10.1016/j.neuroimage.2013.05.041)
29
('hcps1200', 'meggamma2', 'fsLR', '4k')
MEG high gamma (60-90 Hz) power distribution from the Human Connectome Project S1200 release
MEG; functional33 (17)22-35Shafiei et al., 2022, Plos Biology (doi.org/10.1371/journal.pbio.3001735)
Van Essen et al., 2013, Neuroimage (doi.org/10.1016/j.neuroimage.2013.05.041)
30
('hcps1200', 'megtheta', 'fsLR', '4k')
MEG theta (5-7 Hz) power distribution from the Human Connectome Project S1200 release
MEG; functional33 (17)22-35Shafiei et al., 2022, Plos Biology (doi.org/10.1371/journal.pbio.3001735)
Van Essen et al., 2013, Neuroimage (doi.org/10.1016/j.neuroimage.2013.05.041)
31
('hcps1200', 'megtimescale', 'fsLR', '4k')MEG intrinsic timescale from the Human Connectome Project S1200 releaseMEG; functional33 (17)22-35Shafiei et al., 2023 bioRxiv (doi.org/10.1101/2023.01.23.525101)Van Essen et al., 2013, Neuroimage (doi.org/10.1016/j.neuroimage.2013.05.041)
32
('hcps1200', 'myelinmap', 'fsLR', '32k')MRI T1w/T2w ratio from the Human Connectome Project S1200 releaseMRI; structural22-35Glasser et al., 2016, Nature (doi.org/10.1038/nature18933)
33
('hcps1200', 'thickness', 'fsLR', '32k')MRI cortical thickness from the Human Connectome Project S1200 releaseMRI; structural22-35Glasser et al., 2016, Nature (doi.org/10.1038/nature18933)
34
('hesse2017', 'methylreboxetine', 'MNI152', '3mm')
PET tracer binding (BPnd) to NET (norepinephrine transporter)receptors; PET10 (n/a)33.3 (mean)Hesse et al., 2017, Eur J Nucl Med Mol Imaging (doi.org/10.1007/s00259-016-3590-3)
35
('hill2010', 'devexp', 'fsLR', '164k')Developmental cortical expansionMRI; structuralHill et al., 2010, PNAS (doi.org/10.1073/pnas.1001229107)
36
('hill2010', 'evoexp', 'fsLR', '164k')Evolutionary cortical expansionMRI; structuralHill et al., 2010, PNAS (doi.org/10.1073/pnas.1001229107)
37
('hillmer2016', 'flubatine', 'MNI152', '1mm')PET tracer binding (Vt) to a4b2 (acetylcholine receptor)receptors; PET30 (20)
33.50 +/- 10.71
Hillmer et al., 2016, Neuroimage (doi.org/10.1016/j.neuroimage.2016.07.026)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)		Baldassarri et al., 2018, Nicotine Tob Res (doi.org/10.1093/ntr/ntx091)
38
('jaworska2020', 'fallypride', 'MNI152', '1mm')PET tracer binding (BPnd) to D2 (dopamine receptor)receptors; PET49 (16)18.41 +/- 0.57Jaworska et al., 2020, Neuropsychopharm (doi.org/10.1038/s41386-020-0662-7)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)
39
('kaller2017', 'sch23390', 'MNI152', '3mm')PET tracer binding (BPnd) to D1 (dopamine receptor)receptors; PET13 (6)33 +/- 13Kaller et al., 2017, Eur J Nucl Med Mol Imaging (doi.org/10.1007/s00259-017-3645-0)
40
('kantonen2020', 'carfentanil', 'MNI152', '3mm')PET tracer binding (BPnd) to MOR (mu-opioid receptor)receptors; PET204 (132)32.3 +/- 10.8Kantonen et al., 2020, Neuroimage (doi.org/10.1016/j.neuroimage.2020.116922)
41
('kim2020', 'ps13', 'MNI152', '2mm')PET tracer binding (Vt) to COX-1 (cyclooxygenase-1)PET10 (6)29.3 +/- 7.2Kim et al., 2020, Eur J Nucl Med Mol Imaging (doi.org/10.1007/s00259-020-04855-2)
Greve et al., 2023, OpenNeuro. (doi:10.18112/openneuro.ds004401.v1.0.1)
42
('laurikainen2018', 'fmpepd2', 'MNI152', '1mm')PET tracer binding (Vt) to CB1 (cannabinoid receptor)receptors; PET22 (11)27.5 +/- 8.05Laurikainen et al., 2019, Neuroimage (doi.org/10.1016/j.neuroimage.2018.10.013)
43
('lois2018', 'pbr28', 'MNI152', '2mm')PET tracer binding (SUVR) to TSPO (translocator protein)PET6 (2)57.8 +/- 8.1Lois et al., 2018, ACS Chem Neurosci (doi.org/10.1021/acschemneuro.8b00072)
Gonzalez & Lois, 2018, Zeonodo (doi.org/10.5281/zenodo.1174364)
44
('lukow2022', 'ro154513', 'MNI152', '2mm')PET tracer binding (BPnd) to GABAa receptor, alpha5 subunitPET10 (6)25.40 +/- 3.20Lukow et al., 2022, Communicatinos Biology (doi.org/10.1038/s42003-022-03268-1)
45
('malen2022', 'raclopride', 'MNI152', '2mm')PET tracer binding (BPnd) to D2 (dopamine receptor)receptors; PET156 (120)27.76 +/- 9.44Malen et al., 2022, NeuroImage (doi.org/10.1016/j.neuroimage.2022.119149)
46
('margulies2016', 'fcgradient01', 'fsLR', '32k')Diffusion map embedding gradient 1 of group-averaged functional connectivityfunctional; MRI; fMRI820 (n/a)Margulies et al., 2016, PNAS (doi.org/10.1073/pnas.1608282113)
47
('margulies2016', 'fcgradient02', 'fsLR', '32k')Diffusion map embedding gradient 2 of group-averaged functional connectivityfunctional; MRI; fMRI820 (n/a)Margulies et al., 2016, PNAS (doi.org/10.1073/pnas.1608282113)
48
('margulies2016', 'fcgradient03', 'fsLR', '32k')Diffusion map embedding gradient 3 of group-averaged functional connectivityfunctional; MRI; fMRI820 (n/a)Margulies et al., 2016, PNAS (doi.org/10.1073/pnas.1608282113)
49
('margulies2016', 'fcgradient04', 'fsLR', '32k')Diffusion map embedding gradient 4 of group-averaged functional connectivityfunctional; MRI; fMRI820 (n/a)Margulies et al., 2016, PNAS (doi.org/10.1073/pnas.1608282113)
50
('margulies2016', 'fcgradient05', 'fsLR', '32k')Diffusion map embedding gradient 5 of group-averaged functional connectivityfunctional; MRI; fMRI820 (n/a)Margulies et al., 2016, PNAS (doi.org/10.1073/pnas.1608282113)
51
('margulies2016', 'fcgradient06', 'fsLR', '32k')Diffusion map embedding gradient 6 of group-averaged functional connectivityfunctional; MRI; fMRI820 (n/a)Margulies et al., 2016, PNAS (doi.org/10.1073/pnas.1608282113)
52
('margulies2016', 'fcgradient07', 'fsLR', '32k')Diffusion map embedding gradient 7 of group-averaged functional connectivityfunctional; MRI; fMRI820 (n/a)Margulies et al., 2016, PNAS (doi.org/10.1073/pnas.1608282113)
53
('margulies2016', 'fcgradient08', 'fsLR', '32k')Diffusion map embedding gradient 8 of group-averaged functional connectivityfunctional; MRI; fMRI820 (n/a)Margulies et al., 2016, PNAS (doi.org/10.1073/pnas.1608282113)
54
('margulies2016', 'fcgradient09', 'fsLR', '32k')Diffusion map embedding gradient 9 of group-averaged functional connectivityfunctional; MRI; fMRI820 (n/a)Margulies et al., 2016, PNAS (doi.org/10.1073/pnas.1608282113)
55
('margulies2016', 'fcgradient10', 'fsLR', '32k')Diffusion map embedding gradient 10 of group-averaged functional connectivityfunctional; MRI; fMRI820 (n/a)Margulies et al., 2016, PNAS (doi.org/10.1073/pnas.1608282113)
56
('mueller2013', 'intersubjvar', 'fsLR', '164k')Intersubject variability of resting-state functional connectivity.functional; MRI; fMRI25 (16)51.8 +/- 6.99Mueller et al., 2013, Neuron (doi.org/10.1016/j.neuron.2012.12.028)
57
('naganawa2020', 'lsn3172176', 'MNI152', '1mm')PET tracer binding (BPnd) to M1 (acetylcholine receptor)receptors; PET24 (13)
40.45 +/- 11.71
Naganawa et al., 2020, J Nucl Med (doi.org/10.2967/jnumed.120.246967)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)
58
('neurosynth', 'cogpc1', 'MNI152', '2mm')PC1 of Neurosynth terms in the Cognitive Atlas (123 terms total)
functional; structural; meta-analysis; MRI; fMRI
Yarkoni et al., 2011, Nat Methods (doi.org/10.1038/nmeth.1635)Poldrack et al., 2011, Front Neuroinform (doi.org/10.3389/fninf.2011.00017)
59
('norgaard2021', 'flumazenil', 'MNI152', '1mm')
PET and autoradiography informed GABAa benzodiazepine binding-site density (Bmax; gaba receptor)
receptors; PET16 (7)26.6 +/- 8Norgaard et al., 2021, Neuroimage (doi.org/10.1016/j.neuroimage.2021.117878)
60
('norgaard2021', 'flumazenil', 'fsaverage', '164k')
PET and autoradiography informed GABAa benzodiazepine binding-site density (Bmax; gaba receptor)
receptors; PET16 (7)26.6 +/- 8Norgaard et al., 2021, Neuroimage (doi.org/10.1016/j.neuroimage.2021.117878)
61
('normandin2015', 'omar', 'MNI152', '1mm')PET tracer binding (Vt) to CB1 (cannabinoid receptor)receptors; PET77 (49)30.01 +/- 8.87Normandin et al., 2015, J Cereb Blood Flow Metab (doi.org/10.1038/jcbfm.2015.46)D’Souza et al., 2016, Biol Psychiatry Cogn Neurosci Neuroimaging (doi.org/10.1016/j.bpsc.2015.09.008)
Ranganathan et al 2016 Biol Psychiatry (doi.org/10.1016/j.biopsych.2015.08.021)
Neumeister et al 2012 Alcohol Clin Exp Res (doi.org/10.1111/j.1530-0277.2012.01815.x)
62
('radnakrishnan2018', 'gsk215083', 'MNI152', '1mm')
PET tracer binding (BPnd) to 5-HT6 (serotonin receptor)receptors; PET30 (30)36.6 +/- 9.04Radhakrishnan et al., 2018, J Nucl Med (doi.org/10.2967/jnumed.117.206516)
Radhakrishnan et al., 2020, Psychiatry Res Neuroimaging (doi.org/10.1016/j.pscychresns.2019.111007)
63
('raichle', 'cbf', 'fsLR', '164k')Cerebral blood flowfunctional; MRI33 (14)25.4 +/- 2.6Vaishnavi et al., 2010, PNAS (doi.org/10.1073/pnas.1010459107)
64
('raichle', 'cbv', 'fsLR', '164k')Cerebral blood volumefunctional; MRI33 (14)25.4 +/- 2.6Vaishnavi et al., 2010, PNAS (doi.org/10.1073/pnas.1010459107)
65
('raichle', 'cmr02', 'fsLR', '164k')Oxygen metabolismfunctional; MRI33 (14)25.4 +/- 2.6Vaishnavi et al., 2010, PNAS (doi.org/10.1073/pnas.1010459107)
66
('raichle', 'cmrglc', 'fsLR', '164k')Glucose metabolismfunctional; MRI33 (14)25.4 +/- 2.6Vaishnavi et al., 2010, PNAS (doi.org/10.1073/pnas.1010459107)
67
('reardon2018', 'scalinghcp', 'civet', '41k')Cortical areal scaling during development from the HCP dataset (S1200 release)structural; MRI1113 (n/a)Reardon et al., 2018, Science (doi.org/10.1126/science.aar2578)
68
('reardon2018', 'scalingnih', 'civet', '41k')Cortical areal scaling during development from the NIH datasetstructural; MRI1531 (n/a) 5-25Reardon et al., 2018, Science (doi.org/10.1126/science.aar2578)
69
('reardon2018', 'scalingpnc', 'civet', '41k')Cortical areal scaling during development from the PNC datasetstructural; MRI1373 (n/a) 8-23Reardon et al., 2018, Science (doi.org/10.1126/science.aar2578)
70
('rosaneto', 'abp688', 'MNI152', '1mm')PET tracer binding (BPnd) to mGluR5 (glutamate receptor)receptors; PET22 (12)67.9 +/- 9.6Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)
71
('sandiego2015', 'flb457', 'MNI152', '1mm')PET tracer binding (BPnd) to D2 (dopamine receptor)receptors; PET55 (26)32.45 +/- 9.69Sandiego et al., 2015, J Cereb Blood Flow Metab (doi.org/10.1038/jcbfm.2014.237)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)		Smith et al 2017 J Cereb Blood Flow Metab (doi.org/10.1177/0271678x17737693 )
Zakiniaeiz et al 2019 Neuropsychopharm (doi.org/10.1038/s41386-019-0456-y)
Slifstein et al 2015 JAMA Psychiatry (doi.org/10.1001/jamapsychiatry.2014.2414)
Sandiego et al 2018 Neuropsychopharm (doi.org/10.1038/npp.2017.223)
72
('sasaki2012', 'fepe2i', 'MNI152', '1mm')PET tracer binding (BPnd) to DAT (dopamine transporter)receptors; PET6 (6)31.06 +/- 7.7Sasaki et al., 2012, J Nucl Med (doi.org/10.2967/jnumed.111.101626)
73
('satterthwaite2014', 'meancbf', 'MNI152', '1mm')
Cerebral blood flowfunctional; ASL922 (n/a) 8-22Satterthwaite et al., 2014, PNAS (doi.org/10.1073/pnas.1400178111)
74
('savli2012', 'altanserin', 'MNI152', '3mm')PET tracer binding (BPnd) to 5-HT2a (serotonin receptor)receptors; PET19 (11)28.2 +/- 5.7Savli et al., 2012, Neuroimage (doi.org/10.1016/j.neuroimage.2012.07.001)
75
('savli2012', 'dasb', 'MNI152', '3mm')PET tracer binding (BPnd) to 5-HTT (serotonin transporter)receptors; PET18 (12)30.5 +/- 9.5Savli et al., 2012, Neuroimage (doi.org/10.1016/j.neuroimage.2012.07.001)
76
('savli2012', 'p943', 'MNI152', '3mm')PET tracer binding (BPnd) to 5-HT1b (serotonin receptor)receptors; PET23 (15)28.7 +/- 7Savli et al., 2012, Neuroimage (doi.org/10.1016/j.neuroimage.2012.07.001)
77
('savli2012', 'way100635', 'MNI152', '3mm')PET tracer binding (BPnd) to 5-HT1a (serotonin receptor)receptors; PET35 (18)26.3 +/- 5.2Savli et al., 2012, Neuroimage (doi.org/10.1016/j.neuroimage.2012.07.001)
78
('smart2019', 'abp688', 'MNI152', '1mm')PET tracer binding (BPnd) to mGluR5 (glutamate receptor)receptors; PET73 (25)19.9 +/- 3.04Smart et al., 2019, Eur J Nucl Med Mol Imaging (doi.org/10.1007/s00259-018-4252-4)
Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)
79
('smith2017', 'flb457', 'MNI152', '1mm')PET tracer binding (BPnd) to D2 (dopamine receptor)receptors; PET37 (17)
48.36 +/- 16.93
Smith et al., 2017, J Cereb Blood Flow Metab (doi.org/10.1177/0271678X17737693)
80
('sydnor2021', 'SAaxis', 'fsLR', '32k')Sensory-association mean rank axisSydnor et al., 2021, Neuron (doi.org/10.1016/j.neuron.2021.06.016)
81
('tuominen', 'feobv', 'MNI152', '2mm')PET tracer binding (SUVR) to VAChT (acetylcholine transporter)receptors; PET4 (3)37 +/- 10.2Hansen et al., 2022, Nat Neurosci (doi.org/10.1038/s41593-022-01186-3)
82
('turtonen2020', 'carfentanil', 'MNI152', '1mm')PET tracer binding (BPnd) to MOR (mu-opioid receptor)receptors; PET39 (19)39.38 +/- 5.05
Turtonen et al., 2021, Biol Psychiatry Cogn Neurosci Neuroimaging (doi.org/10.1016/j.bpsc.2020.10.013v)
83
('vijay2018', 'ly2795050', 'MNI152', '2mm')PET tracer binding (Vt) to KOR (kappa-opioid receptor)receptors; PET28 (19)33.5 +/- 11.3
Vijay et al., 2018, Neuropsychopharmacology (https://doi.org/10.1038/s41386-018-0199-1)
84
('wey2016', 'martinostat', 'MNI152', '2mm')PET tracer binding (SUVR) to class 1 HDAC isoforms 1, 2, and 3 (histone deacetylase)PET8 (4)28.6 +/- 7.6Wey et al., 2016, Science Transl Med (doi: 10.1126/scitranslmed.aaf7551)https://identifiers.org/neurovault.collection:2043
85
('xu2020', 'FChomology', 'fsLR', '32k')Cross-species functional homologyfunctional; MRIXu et al., 2020, Neuroimage (doi.org/10.1016/j.neuroimage.2020.117346)
86
('xu2020', 'evoexp', 'fsLR', '32k')Evolutionary cortical expansionstructural; MRIXu et al., 2020, Neuroimage (doi.org/10.1016/j.neuroimage.2020.117346)
87
88
89
90
91
92
93
94
95
96
97
98
99
100